Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
194M
-
Number of holders
-
507
-
Total 13F shares, excl. options
-
180M
-
Shares change
-
+4.04M
-
Total reported value, excl. options
-
$22.2B
-
Value change
-
+$737M
-
Put/Call ratio
-
0.79
-
Number of buys
-
280
-
Number of sells
-
-206
-
Price
-
$123.34
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q2 2020
624 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q2 2020.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 507 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 180M shares
of 194M outstanding shares and own 92.97% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (22.1M shares), PRIMECAP MANAGEMENT CO/CA/ (17.9M shares), VANGUARD GROUP INC (16.9M shares), BlackRock Inc. (16M shares), JENNISON ASSOCIATES LLC (7.59M shares), BAKER BROS. ADVISORS LP (7.59M shares), Clearbridge Investments, LLC (5.91M shares), STATE STREET CORP (5.15M shares), Dodge & Cox (3.62M shares), and AMERIPRISE FINANCIAL INC (3.13M shares).
This table shows the top 507 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.